Skip to content

Author

J. Cerhan

We have 4 of 146 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

Patterns of care, outcomes, and prognostics for transformed follicular lymphoma in the rituximab era.

Histologic transformation (HT) is the leading of death in follicular lymphoma (FL), yet outcomes remain poorly defined due to small cohorts and heterogenous definitions. To characterize outcomes and treatment patterns in the rituximab era we analyzed 344 patients with an initial biopsy-confirmed FL diagnosis between 20...

J. Day, M. Larson, C. Casulo et al. · 0 citations
Open access Aug 2026

Perinatal and Early-Life Exposures and Risk of Non-Hodgkin Lymphoma

Greater weight at birth, in childhood, and in late adolescence were all associated with greater risk of NHL, and overall associations did not substantively vary by major NHL subtype.

G. Cholack, G. Kleinstern, Dennis P. Robinson et al. · 0 citations
Open access Aug 2026

Transforming lymphoma outcomes through international real-world data collaborations: the Global Lymphoma Registry Alliance roadmap.

This White Paper written by the Global Lymphoma Registry Alliance (LyRA) discusses the importance and value of lymphoma registries for different stakeholders as well as benefits of forming a global alliance of the registry network.

Eliza A. Hawkes, E. Chung, M. Bishton et al. · 0 citations
Open access Aug 2026

Malignant B-cell States Orchestrate Spatially Organized Immune Ecosystems in B-cell Lymphomas

Findings establish malignant differentiation state as a causal determinant of immune architecture across GC-derived lymphomas and identify lineage-directed immune reprogramming as a potential therapeutic strategy.

P. Mondello, A. Sadekova, ksenia fede et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.